While hemoglobin SE (HBSE), a rare genotype of sickle cell disease (SCD), has historically been considered a mild form of SCD with benign clinical course, an international multicenter study has found evidence to the contrary. A team of investigators from centers in Qatar, Pakistan, Egypt, and Italy performed a systematic review of the medical literature and identified 68 patients reported with HSBE.
Journal of Translational Medicine